The Office of Technology Commercialization (OTC) helps develop ideas into promising new technologies and facilitates their transfer to external partners, including existing companies and entrepreneurial partners ready to establish new ventures, to advance the practice of pediatrics and general health care. Our list of technologies developed by our innovative researchers and clinicians, which ranges from early-stage technologies to market-ready products, is diverse and ever-growing. The number of active licensing agreements grew from seven active deals in 2012 to 89 active deals by the end of 2021. In 2021, the OTC assessed over 70 new invention disclosures, filed over 125 patent applications and completed 18 licensing deals. Find the right licensing opportunity that fits your needs. We offer access to two distinct databases to help you with your search. Cayuse Inventions Search our entire technology catalog/library of licensable technologies disclosed to our office. Learn more about the technologies available in each category, the inventors behind the innovations, and the licensing associate to manage them. Our comprehensive portfolio spans a wide array of research fields and categories of market applications. Search the Cayuse Inventions database by disease, disorder or technology type.
Biomarkers
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
End User Innovation
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene Therapies & AAV Production
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research Tools/Clinical Tools/Other
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Tissue Engineering
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
To license a technology, contact the assigned OTC representative. In-PART Gain access to information regarding our revolutionary technologies and connect with industry experts to discuss licensing and commercializing these technologies. Our team can also help you with your search. If you would like assistance, please call (614) 355-1850 or email Tech.Commercialization@NationwideChildrens.org. If you’re not interested in beginning the licensing process today, our team can help you stay informed about available technologies developed at Nationwide Children’s Hospital. Learn more about available technologies at our annual Technology Showcase event. At the annual Technology Showcase, held each year in March, the OTC highlights new inventions and startup companies generated from research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital through a series of special presentations.
Want to learn more about technologies currently available to license?
View Past Event Recordings and Register for the Next Event
The Office of Technology Commercialization (OTC) helps develop ideas into promising new technologies and facilitates their transfer to external partners, including existing companies and entrepreneurial partners ready to establish new ventures, to advance the practice of pediatrics and general health care. Our list of technologies developed by our innovative researchers and clinicians, which ranges from early-stage technologies to market-ready products, is diverse and ever-growing. The number of active licensing agreements grew from seven active deals in 2012 to 89 active deals by the end of 2021. In 2021, the OTC assessed over 70 new invention disclosures, filed over 125 patent applications and completed 18 licensing deals. Find the right licensing opportunity that fits your needs. We offer access to two distinct databases to help you with your search. Cayuse Inventions Search our entire technology catalog/library of licensable technologies disclosed to our office. Learn more about the technologies available in each category, the inventors behind the innovations, and the licensing associate to manage them. Our comprehensive portfolio spans a wide array of research fields and categories of market applications. Search the Cayuse Inventions database by disease, disorder or technology type.
Biomarkers
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
End User Innovation
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene Therapies & AAV Production
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research Tools/Clinical Tools/Other
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Tissue Engineering
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
To license a technology, contact the assigned OTC representative. In-PART Gain access to information regarding our revolutionary technologies and connect with industry experts to discuss licensing and commercializing these technologies. Our team can also help you with your search. If you would like assistance, please call (614) 355-1850 or email Tech.Commercialization@NationwideChildrens.org. If you’re not interested in beginning the licensing process today, our team can help you stay informed about available technologies developed at Nationwide Children’s Hospital. Learn more about available technologies at our annual Technology Showcase event. At the annual Technology Showcase, held each year in March, the OTC highlights new inventions and startup companies generated from research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital through a series of special presentations.
Want to learn more about technologies currently available to license?
View Past Event Recordings and Register for the Next Event
The Office of Technology Commercialization (OTC) helps develop ideas into promising new technologies and facilitates their transfer to external partners, including existing companies and entrepreneurial partners ready to establish new ventures, to advance the practice of pediatrics and general health care. Our list of technologies developed by our innovative researchers and clinicians, which ranges from early-stage technologies to market-ready products, is diverse and ever-growing. The number of active licensing agreements grew from seven active deals in 2012 to 89 active deals by the end of 2021. In 2021, the OTC assessed over 70 new invention disclosures, filed over 125 patent applications and completed 18 licensing deals. Find the right licensing opportunity that fits your needs. We offer access to two distinct databases to help you with your search. Cayuse Inventions Search our entire technology catalog/library of licensable technologies disclosed to our office. Learn more about the technologies available in each category, the inventors behind the innovations, and the licensing associate to manage them. Our comprehensive portfolio spans a wide array of research fields and categories of market applications. Search the Cayuse Inventions database by disease, disorder or technology type.
The Office of Technology Commercialization (OTC) helps develop ideas into promising new technologies and facilitates their transfer to external partners, including existing companies and entrepreneurial partners ready to establish new ventures, to advance the practice of pediatrics and general health care.
Our list of technologies developed by our innovative researchers and clinicians, which ranges from early-stage technologies to market-ready products, is diverse and ever-growing. The number of active licensing agreements grew from seven active deals in 2012 to 89 active deals by the end of 2021. In 2021, the OTC assessed over 70 new invention disclosures, filed over 125 patent applications and completed 18 licensing deals.
Find the right licensing opportunity that fits your needs. We offer access to two distinct databases to help you with your search.
Cayuse Inventions
Search our entire technology catalog/library of licensable technologies disclosed to our office. Learn more about the technologies available in each category, the inventors behind the innovations, and the licensing associate to manage them.
Our comprehensive portfolio spans a wide array of research fields and categories of market applications. Search the Cayuse Inventions database by disease, disorder or technology type.
Biomarkers
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
End User Innovation
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene Therapies & AAV Production
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research Tools/Clinical Tools/Other
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Tissue Engineering
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
Biomarkers
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
End User Innovation
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene Therapies & AAV Production
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research Tools/Clinical Tools/Other
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Tissue Engineering
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
Biomarkers
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
End User Innovation
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene Therapies & AAV Production
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research Tools/Clinical Tools/Other
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Tissue Engineering
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
Novel biomarkers are measurable characteristics that have been newly identified as ways to detect and measure normal biological processes, pathogenic processes or responses to interventions.
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
These innovations aim to improve clinical or business practices and patient outcomes and are being developed by those who will ultimately use them.
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Gene therapy is the process of replacing impaired or harmful genetic material with new material, or machinery to make the new material, to treat various conditions, including neuromuscular and neurodegenerative diseases, developmental diseases, lysosomal storage disorders, ischemia and re-perfusion injury, neonatal hypertension, cancers and infectious diseases. Inventions in this space span production methodology to vector design and delivery.
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Research tools are vehicles that broadly facilitate research and related activities. They enable researchers to collect, organize, analyze, visualize and publicize research outputs. Examples include questionnaires, surveys and interviews.
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
Therapeutics are treatments used to alleviate or prevent a particular disease. Technologies in this space include cell-based treatments like engineered chimeric antigen receptor (CAR) T-cells and natural killer (NK) cells, protective vaccines and small molecules effective against indications like infection, cancer and allergy, to name a few.
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
The practice of combining scaffolds, cells, and biologically active molecules into functional tissues. Tissue engineering holds incredible potential for repairing birth defects, allowing a patient’s own cells to be used to “grow” new tissue or organs for repair.
To license a technology, contact the assigned OTC representative. In-PART Gain access to information regarding our revolutionary technologies and connect with industry experts to discuss licensing and commercializing these technologies. Our team can also help you with your search. If you would like assistance, please call (614) 355-1850 or email Tech.Commercialization@NationwideChildrens.org. If you’re not interested in beginning the licensing process today, our team can help you stay informed about available technologies developed at Nationwide Children’s Hospital. Learn more about available technologies at our annual Technology Showcase event. At the annual Technology Showcase, held each year in March, the OTC highlights new inventions and startup companies generated from research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital through a series of special presentations.
To license a technology, contact the assigned OTC representative. In-PART Gain access to information regarding our revolutionary technologies and connect with industry experts to discuss licensing and commercializing these technologies. Our team can also help you with your search. If you would like assistance, please call (614) 355-1850 or email Tech.Commercialization@NationwideChildrens.org. If you’re not interested in beginning the licensing process today, our team can help you stay informed about available technologies developed at Nationwide Children’s Hospital. Learn more about available technologies at our annual Technology Showcase event. At the annual Technology Showcase, held each year in March, the OTC highlights new inventions and startup companies generated from research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital through a series of special presentations.
To license a technology, contact the assigned OTC representative.
In-PART
Gain access to information regarding our revolutionary technologies and connect with industry experts to discuss licensing and commercializing these technologies.
Our team can also help you with your search. If you would like assistance, please call (614) 355-1850 or email Tech.Commercialization@NationwideChildrens.org. If you’re not interested in beginning the licensing process today, our team can help you stay informed about available technologies developed at Nationwide Children’s Hospital.
Learn more about available technologies at our annual Technology Showcase event.
At the annual Technology Showcase, held each year in March, the OTC highlights new inventions and startup companies generated from research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital through a series of special presentations.
Want to learn more about technologies currently available to license?
View Past Event Recordings and Register for the Next Event
Want to learn more about technologies currently available to license?
View Past Event Recordings and Register for the Next Event
